111 Stock (NASDAQ:YI)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.77

52W Range

$0.55 - $1.85

50D Avg

$0.76

200D Avg

$0.98

Market Cap

$64.45M

Avg Vol (3M)

$288.92K

Beta

0.39

Div Yield

-

YI Company Profile


111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

CN

Employees

1,520

IPO Date

Sep 12, 2018

Website

YI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Drugs$13.88B$11.68B-
Service, Other$35.95M$44.78M-
Service$106.22M$94.20M-
Product$14.84B$12.33B-
Other Products$170.23M--
Nutritional Supplements$631.12M--
Medical Supplies And Devices$157.50M--
MP Service$70.27M$68.48M$52.31M
Contact lenses.--$38.00K
Medical supplies and devices--$124.92M
Nutritional supplements--$442.50M
Other Services--$41.89M
Other products.--$83.14M

Fiscal year ends in Dec 23 | Currency in CNY

YI Financial Summary


Dec 23Dec 22Dec 21
Revenue$14.95B$13.52B$12.43B
Operating Income$-350.10M$-371.00M$-642.14M
Net Income$-392.69M$-408.50M$-662.97M
EBITDA$-309.28M$-354.75M$-617.47M
Basic EPS$-4.66$-4.90$-7.99
Diluted EPS$-4.66$-4.90$-7.99

Fiscal year ends in Dec 23 | Currency in CNY

Latest Earnings Call Transcripts


Q3 24Nov 27, 24 | 12:56 PM
Q2 24Aug 29, 24 | 4:06 PM
Q1 24May 23, 24 | 12:00 AM

Peer Comparison


TickerCompany
LFLYLeafly Holdings, Inc.
HITIHigh Tide Inc.
PETSPetMed Express, Inc.
WBAWalgreens Boots Alliance, Inc.
CJJDChina Jo-Jo Drugstores, Inc.